SORBI, Claudia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.014
EU - Europa 4.854
AS - Asia 3.662
SA - Sud America 580
Continente sconosciuto - Info sul continente non disponibili 181
AF - Africa 111
OC - Oceania 30
Totale 18.432
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.783
IT - Italia 1.215
GB - Regno Unito 1.061
SG - Singapore 1.032
CN - Cina 906
SE - Svezia 644
DE - Germania 606
VN - Vietnam 465
HK - Hong Kong 453
BR - Brasile 439
FI - Finlandia 296
RU - Federazione Russa 230
FR - Francia 183
KR - Corea 129
BD - Bangladesh 128
CA - Canada 127
UA - Ucraina 125
IN - India 116
TR - Turchia 105
BE - Belgio 92
NL - Olanda 73
BG - Bulgaria 70
ID - Indonesia 56
IE - Irlanda 52
MX - Messico 47
JP - Giappone 43
AR - Argentina 40
PL - Polonia 37
RO - Romania 33
LT - Lituania 31
IQ - Iraq 28
IR - Iran 28
ES - Italia 25
EC - Ecuador 24
NZ - Nuova Zelanda 23
AT - Austria 22
CO - Colombia 22
EG - Egitto 22
ZA - Sudafrica 19
AE - Emirati Arabi Uniti 18
TW - Taiwan 18
CL - Cile 17
IL - Israele 17
VE - Venezuela 15
PK - Pakistan 14
KE - Kenya 13
CR - Costa Rica 11
NO - Norvegia 11
CH - Svizzera 10
KZ - Kazakistan 10
MA - Marocco 10
MY - Malesia 10
PH - Filippine 10
TH - Thailandia 10
UZ - Uzbekistan 10
SA - Arabia Saudita 9
DZ - Algeria 8
NI - Nicaragua 8
TN - Tunisia 8
AU - Australia 7
CZ - Repubblica Ceca 7
DK - Danimarca 7
GT - Guatemala 7
JM - Giamaica 7
JO - Giordania 7
NG - Nigeria 7
AZ - Azerbaigian 6
CI - Costa d'Avorio 6
HN - Honduras 6
NP - Nepal 6
PY - Paraguay 6
UY - Uruguay 6
CW - ???statistics.table.value.countryCode.CW??? 5
PE - Perù 5
PR - Porto Rico 5
BO - Bolivia 4
BY - Bielorussia 4
EE - Estonia 4
EU - Europa 4
LB - Libano 4
PS - Palestinian Territory 4
SN - Senegal 4
AL - Albania 3
BH - Bahrain 3
ET - Etiopia 3
LU - Lussemburgo 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
UG - Uganda 3
AO - Angola 2
DO - Repubblica Dominicana 2
GY - Guiana 2
HU - Ungheria 2
MM - Myanmar 2
OM - Oman 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TG - Togo 2
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
Totale 18.236
Salva come PNG Salva come JPEG
Città #
Ashburn 883
Santa Clara 671
Southend 644
Singapore 636
Fairfield 519
San Jose 447
Hong Kong 430
Chandler 389
Woodbridge 353
Council Bluffs 331
Ann Arbor 329
Munich 324
Chicago 310
Hefei 282
Nyköping 280
Houston 278
Seattle 262
New York 250
Jacksonville 224
Helsinki 218
Beijing 205
Wilmington 193
Cambridge 192
Los Angeles 191
Modena 190
Dearborn 189
London 151
Ho Chi Minh City 147
Hanoi 105
Milan 100
Seoul 98
Brussels 91
Salt Lake City 83
The Dalles 78
Sofia 66
San Diego 63
Eugene 53
Princeton 53
Elk Grove Village 52
Lauterbourg 50
Bologna 47
Columbus 47
Dublin 47
Izmir 46
Buffalo 45
Orem 45
Dallas 44
São Paulo 44
Washington 43
Tampa 41
Moscow 40
Tokyo 40
Toronto 39
Amsterdam 36
Fremont 35
Phoenix 35
Rome 35
Da Nang 33
Jakarta 33
Shanghai 29
Boardman 28
Frankfurt am Main 28
Redwood City 28
Bremen 25
Mexico City 25
Warsaw 25
Auckland 23
Turku 23
Denver 22
Sochi 22
Brooklyn 20
Reggio Emilia 20
Sterling 20
Yalova 20
Atlanta 19
Chennai 19
Philadelphia 19
Montreal 18
Mumbai 18
Augusta 17
Norwalk 17
Haiphong 16
Hillsboro 16
Naples 16
Parma 16
San Francisco 16
Grafing 15
Jyväskylä 15
Boston 14
Des Moines 14
Guangzhou 14
Kent 13
Lancaster 13
Paris 13
Stockholm 13
Baghdad 12
Dhaka 12
Horia 12
Leawood 12
Manchester 12
Totale 11.934
Salva come PNG Salva come JPEG
Nome #
1,3-Dioxolane-Based Ligands Incorporating a Lactam or Imide moiety: Structure-Affinity/Activity Relationship at alpha1–Adrenoceptor subtypes and at 5-HT1A Receptors 773
(2,2-difenil-[1,3]-diossolan-4ilmetil)-(3-fenil-propil)-ammina: nuovo agonista parziale del recettore serotoninergico 5-HT1A 663
1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity 601
1,3-Dioxolane-Based Ligands as a Novel Class of Alpha1-Adrenoceptor Antagonists 550
1,3-Dioxolane-Based Ligands as Rigid Analogues ofNaftopidil: Structure–Affinity/Activity Relationships at a1and 5-HT1A Receptors 524
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 478
1,3-dioxolane-based ligands in the search for alpha1-adrenergic antagonists. 467
(2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenylpropyl)-amine: a Potent and Selective 5-HT1A Receptor Agonist 464
Enantiomeric resolution of [(2,2-diphenyl-1,3-dioxolan-4-yl)methyl](2-phenoxyethyl)amine, a potent α1and 5-HT1Areceptor ligand: an in vitro and computational study 458
Discovery of a new 5-HT1A receptor agonist, acting ‘in vivo’ in a rat model of anxiety and depression 448
A New and Versatile Synthesis of 1,3-Dioxan-5-yl-pyrimidine and Purine Nucleoside Analogues 412
A homology modelling-driven study leading to the discovery of the first mouse trace amine-associated receptor 5 (TAAR5) antagonists 406
Discovery Of New Sigma-2 Receptor Agonist Endowed With Antiproliferative Activity 387
Synthesis, biological evaluation and molecular modeling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT1A receptor agonists 372
Diastereoselective Synthesis of (1,3-Dioxan-4-yl)pyrimidine and Purin Nucleoside Analogues 367
Structure-Activity Relationship within a new series of σ1 and σ2 receptor ligands: identification of a novel σ2R agonist (BS148) with selective toxicity against metastatic melanoma 355
Synthesis and structure-activity relationships of 1-aralkyl-4- benzylpiperidine and 1-aralkyl-4-benzylpiperazine derivatives as potent σ ligands 354
Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptors 353
Discovery of a new series of 5-HT1A receptor agonists 349
Synthesis of 6-O-methotrexylhyaluronan as a drug delivery system 340
Scouting Sigma Receptor Ligands As New Tools For The Treatment Of Neurodegenerative Diseases And Cancer 325
Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs) 325
BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting 319
Synthesis and biological evaluation of 1,3-dioxolane-based 5-HT 1A receptor agonists for CNS disorders and neuropathic pain 315
DAT atypical inhibitors as novel antipsychotic drugs 315
Synthesis, structural characterization and biological evaluation of 4′-C-methyl- and phenyl-dioxolane pyrimidine and purine nucleosides 311
Synthesis, biological evaluation and molecular modelling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT1A receptor agonists 305
Exhaustive CoMFA and CoMSIA analyses around different chemical entities: A ligand-based study exploring the affinity and selectivity profiles of 5-HT1A ligands 294
Structure-activity relationship at alpha-adrenergic receptors within a series of imidazoline analogues of cirazoline 288
Transacetalization of Acetals with Butane-1,2,4-triol Using Cobalt(II) Chloride and Chlorotrimethylsilane 287
Synthesis and Structure-Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands 287
Synthesis of 5-Methyl-1,3-oxathiolane-based Nucleoside Analogues as Potential Antiviral Agents 282
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer 266
Structure Activity Relationships at 5-HT1A receptors within a novel series of 4-alkyl-1-arylpiperazine derivatives 264
Constrained 1,4-dialkylpiperazines as monoamine transporters inhibitors for cocaine-related abuse 260
Effect of the rigidification of propranolol, a mixed β-adrenoceptor and 5-HT1AR antagonist 257
Pyrrolidine Derivatives as New Ligands for 5-HT1A Receptors 256
Synthesis, enantiomeric separation and docking studies of spiropiperidine analogues as ligands of the nociceptin/orphanin FQ receptor 255
Novel Dithiolane-Based Ligands Combining Sigma and NMDA Receptor Interactions as Potential Neuroprotective Agents 254
Identification of a Potent and Selective 5-HT1AReceptor Agonist with In Vitro and In Vivo Antinociceptive Activity 250
Synthesis, absolute configuration and antimuscarinic activity of the enantiomers of [1-(2,2-diphenyl-[1,3]dioxolan-4-yl)-ethyl]dimethyl-amine 240
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group 238
Synthesis, structural characterization and pharmacological evaluation of spiroxatrine analogs as potential nociceptin/orphanin FQ receptor ligands 232
1,3-Dithiolane as a Privileged Scaffold in Bioactive Derivatives: Chiral Resolution and Assignment of Absolute Configuration 227
Effect of the replacement of the o-methoxyphenyl moiety with nitrogen-containing aromatic rings within N-phenyl-piperazine and phenoxy-ethylamine-based 1,3-dioxo/oxathio/dithiolanes as α1 and 5-HT1A receptor ligands 224
Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agents 218
Derivati 1,3-Diossanici come Antagonisti Muscarinici 214
Synthesis and biological evaluation of Hsp90/HDAC6 dual inhibitors bearing a 2-amino-pyrrolopyrimidine and purine scaffold as potential anticancer drugs to treat prostate cancer 206
Synthesis and structural characterization of spiroxatrine derivatives as potential non-peptide ligands for NOP receptor 206
Synthesis and pharmacological evaluation of Spiroxatrine derivatives as potential ligands for NOP receptor 202
Spiroxatrine derivatives towards 5-HT1A receptor selectivity 199
Relazioni struttura-attività in una nuova serie di ligandi alpha1-adrenergici e 5-HT1A serotoninergici a struttura 2,2-difenil-[1,3]diossolanica 196
IDENTIFICATION OF POTENT 1,3-DIOXOLANE-BASED 5-HT1A RECEPTOR AGONISTS FOR THE TREATMENTS OF CNS DISORDERS AND PAIN 191
Nuova Serie di Ligandi Sigma a Struttura Piperazinica e Piperidinica 188
TB62, A POTENT 5-HT1A SEROTONERGIC FULL AGONIST, ENDOWED WITH DUAL ANTINOCICEPTIVE AND ANXIOLITIC/ANTIDEPRESSANT ACTIVITY 174
Structure-Activity Relationships at alpha1-Adrenoceptor Subtypes within a New Series of 1,3-Dioxolane Derivatives 160
Insights into the Structural Conformations of the Tau Protein in Different Aggregation Status 133
Farmaci attivi sul sistema nervoso adrenergico 103
Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer 45
Totale 18.432
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.001
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.001
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022945 0 0 0 90 49 95 38 65 175 86 206 141
2022/20231.406 221 168 114 151 147 163 42 107 163 46 59 25
2023/2024948 20 51 99 103 216 86 58 126 9 38 69 73
2024/20253.334 161 41 72 163 487 443 472 285 323 156 319 412
2025/20265.639 370 223 462 789 1.069 341 671 289 481 421 277 246
2026/20271.262 154 297 366 445 0 0 0 0 0 0 0 0
Totale 18.432